Synagis 66658-0230
Generic: Palivizumab
Product NDC
66658-0230- Manufacturer
- Swedish Orphan Biovitrum Ab (publ)
- Dosage Form
- Injection, Solution
- Route
- Intramuscular
- Product Type
- Human Prescription Drug
- Marketing Start
- December 9, 1999
- Application
- BLA103770
Need to source Synagis? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Palivizumab | 50 mg/.5mL |
Drug Class
Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]AntibodiesMonoclonal [CS]
Packaging Options(1)
.5 mL in 1 VIAL, SINGLE-DOSE (66658-230-01)